Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor (original) (raw)
Novel S-Adenosylmethionine Decarboxylase Inhibitors for the Treatment of Human African Trypanosomiasis
Nigel Yarlett
Antimicrobial Agents and Chemotherapy, 2009
View PDFchevron_right
Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-alpha-difluoromethylornithine and standard trypanocides
Burt Goldberg, Nigel Yarlett
Antimicrobial Agents and Chemotherapy, 1994
View PDFchevron_right
Pharmacokinetics, Trypanosoma brucei gambiense Efficacy, and Time of Drug Action of DB829, a Preclinical Candidate for Treatment of Second-Stage Human African Trypanosomiasis
Sihyung Yang
Antimicrobial Agents and Chemotherapy, 2013
View PDFchevron_right
Treatment of African Trypanosomiasis with Cordycepin and Adenosine Deaminase Inhibitors in a Mouse Model
Willias Masocha
The Journal of Infectious Diseases, 2005
View PDFchevron_right
Trypanosoma brucei methylthioadenosine phosphorylase protects the parasite from the antitrypanosomal effect of deoxyadenosine: implications for the pharmacology of adenosine antimetabolites
Anders Hofer
The Journal of biological chemistry, 2016
View PDFchevron_right
Prospects for Antiparasitic Drugs. THE CASE OF TRYPANOSOMA BRUCEI, THE CAUSATIVE AGENT OF AFRICAN SLEEPING SICKNESS
Athel Cornish-Bowden
Journal of Biological Chemistry, 1998
View PDFchevron_right
Establishment of a partly DFMO-sensitive primate model of Trypanosoma rhodesiense sleeping sickness
Joseph Ndung'u
Acta Tropica, 1995
View PDFchevron_right
Efficacy of combinations of difluoromethylornithine and bleomycin in a mouse model of central nervous system African trypanosomiasis
Peter McCann
Proceedings of the National Academy of Sciences, 1983
View PDFchevron_right
Individual and combined anti-trypanosomal effects of arteether and diminazene aceturate in the treatment of experimental Trypanosoma brucei brucei infection in rats
IDOKO SUNDAY, NUHU SANI, Veterinary World
Veterinary World, 2020
View PDFchevron_right
Comparative effects of graded doses of diaminanzine ace-turate and fixed doses of levamisole in the treatment of albino mice experimentally infected with Trypanosoma brucei brucei
iniobong ugochukwu
Journal of Experimental and Applied Animal Sciences
View PDFchevron_right
The story of CGP 40 215: studies on its efficacy and pharmacokinetics in African green monkey infected with Trypanosoma brucei rhodesiense
Charity Gichuki
Tropical Medicine & International Health, 2001
View PDFchevron_right
Efficacy of repeated doses of diminazene aceturate (Dinazene®) in the treatment of experimental Trypanosoma brucei infection of Albino rats
Ikenna Ezeh
Iranian journal of veterinary research, 2016
View PDFchevron_right
Trypanocidal Activity of 8-Methyl-5'- Adenosine (Genz-644131), an Adenosylmethionine Decarboxylase Inhibitor
Nigel Yarlett
Antimicrobial Agents and Chemotherapy, 2009
View PDFchevron_right
Effect of diminazene aceturate, levamisole and vitamin C combination therapy in rats experimentally infected with Trypanosoma brucei brucei
emmanuel ikenna
Asian Pacific Journal of Tropical Medicine, 2014
View PDFchevron_right
Evaluation of the Efficacy of a Combination of Artemether and Diminazene Aceturate Therapy in Experimental Trypanosoma brucei Infection in Rats
John Ihedioha
Sahel Journal of Veterinary Sciences, 2020
View PDFchevron_right
Current Treatments to Control African Trypanosomiasis and One Health Perspective
Clara Lima
Microorganisms
View PDFchevron_right
Three Drug Combinations for Late-Stage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in Uganda
Patrice Piola
PLoS Clinical Trials, 2006
View PDFchevron_right
Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis
John Kagira
Acta Tropica, 2008
View PDFchevron_right
Pharmacological Validation of Trypanosoma brucei Phosphodiesterases B1 and B2 as Druggable Targets for African Sleeping Sickness
Michael Pollastri, Stefan Ochiana
Journal of Medicinal Chemistry, 2011
View PDFchevron_right
Trypanosoma brucei CTP synthetase: A target for the treatment of African sleeping sickness
Anders Hofer
Proceedings of The National Academy of Sciences, 2001
View PDFchevron_right
Benzoxaboroles: a new class of potential drugs for human African trypanosomiasis
Nigel Yarlett
Future Medicinal Chemistry, 2011
View PDFchevron_right
About Trypanosoma brucei gambiense , the causative agent of the chronic form of Human African Trypanosomiasis: some findings and proposals
Philippe Truc
African Journal of Biotechnology, 2004
View PDFchevron_right
Pharmacological Validation of Trypanosoma brucei Phosphodiesterases as Novel Drug Targets
Mary Ondrechen
Journal of Infectious Diseases, 2012
View PDFchevron_right